Featured Article

Xylem Pricing Spineometer: 3 of 5 Vertebrae

By Tim J. Smith, PhD December 17, 2024

Xylem, a global water treatment company, had a positive Q3 2024. Revenue rose 1.3 % to $2.1 billion and earnings before interest and taxes rose 47% to $280 million over the same period last year. A review of Xylem’s 31 October 2024 earnings call and associated financial reports provided insight regarding the importance of pricing on performance. Mathew Pine, the CEO of Xylem since January this year, was proud of his team’s…

Read More

In This Issue

Monster Pricing Spineometer: 3 of 5 Vertebrae

By Tim J. Smith, PhD September 26, 2024

Monster Beverage Corporation, a global beverage company, had a positive Q2 2024. Revenue rose 2.4% to $1.9 billion and earnings before interest…

Read More

Boston Scientific Pricing Spineometer: 5 of 5 Vertebrae

By Tim J. Smith, PhD August 26, 2024

Boston Scientific, a global medical technology company, had a strongly positive Q1 2024. Revenue rose 14% to $3.9 billion and earnings before…

Read More

Cadence Pricing Spineometer: 1 of 5 Vertebrae

By Tim J. Smith, PhD August 26, 2024

Cadence Design Systems, a global software and technology company supporting the silicon chip and pharmaceutical design industries among others, had a negative…

Read More

Emerson Pricing Spineometer: 4 of 5 Vertebrae

By Tim J. Smith, PhD August 26, 2024

Emerson, a global electrical products and engineering services concern, had a strongly positive Q2 2024. Revenue rose 17 % to $4.4 billion…

Read More

WIGLAF, STRAIGHT
TO YOUR INBOX